ホーム › 大うつ病性障害 › ジョージア州 › Atlanta
Atlanta、GAにおける大うつ病性障害の臨床試験
Atlantaとその周辺地域（約30マイル以内）の拠点で、大うつ病性障害に関する25件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
被験者募集中第3相
- CenExel - Atlanta Center for Medical Research, Atlanta
- CenExel - iResearch Atlanta, Decatur · 6マイル先
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
被験者募集中第3相
- CenExel iResearch, LLC, Decatur · 6マイル先
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
被験者募集中第3相
- Agile Clinical Research Trials, LLC, Atlanta
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
被験者募集中第3相
- CenExel iResearch, LLC, Decatur · 6マイル先
Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
被験者募集中
- Emory Healthcare, Atlanta
JAK Signaling in Depression
被験者募集中第2相
- Emory University, Atlanta
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
被験者募集中第3相
- The Emory Clinic, Atlanta
- CenExeli Research LLC, Decatur · 6マイル先
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
被験者募集中第3相
- Peachford Hospital-Atlanta Behavioral Research, Atlanta
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
被験者募集中第3相
- Advanced Discovery Research, Atlanta
- Agile Clinical Research Trials, LLC, Atlanta
- iResearch Atlanta LLC, Decatur · 6マイル先
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
被験者募集中第2相
- Seaport Investigator Site, Atlanta
- Seaport Investigator Site, Decatur · 6マイル先
Leucine in Midlife Depression
被験者募集中第2相
- Emory University Hospital, Atlanta
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
被験者募集中第3相
- Delricht Research, Atlanta
- Emory University Brain Health Center, Atlanta
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
被験者募集中第2相
- Draig Clinical Site, Decatur · 6マイル先
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
被験者募集中
- Emory University Hospital, Atlanta
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
被験者募集中第2相
- Draig Clinical Site, Atlanta
- Draig Clinical Site, Decatur · 6マイル先
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
被験者募集中第3相
- Neurocrine Clinical Site, Atlanta
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
被験者募集中第3相
- Advanced Discovery Research, Atlanta
- Synexus - Atlanta, Atlanta
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
被験者募集中第2相
- Denali Health Atlanta, LLC, Stone Mountain · 13マイル先
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
被験者募集中第3相
- Clinical Research Site, Atlanta
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
被験者募集中第3相
- Neurocrine Clinical Site, Atlanta
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
被験者募集中第2相
- Trialmed /ID# 277601, Atlanta
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
被験者募集中早期第1相健康なボランティア歓迎
- Emory University, Atlanta
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
被験者募集中第2相
- CenExcel, Decatur · 6マイル先
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
被験者募集中第2相
- Autobahn Site #112, Decatur · 6マイル先
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
被験者募集中第4相
- Clinical Research Site, Atlanta
他の都市における大うつ病性障害の試験
- New York City, NY36件の研究
- Boston, MA31件の研究
- Philadelphia, PA23件の研究
- Orlando, FL19件の研究
- Miami, FL18件の研究
- Chicago, IL17件の研究
- Tampa, FL17件の研究
- San Diego, CA16件の研究
- Houston, TX16件の研究
- Little Rock, AR14件の研究
- Austin, TX13件の研究
- Las Vegas, NV13件の研究
Atlantaにおける他の研究
- がん（全種類）49件の研究
- 非小細胞肺癌47件の研究
- 多発性骨髄腫42件の研究
- 乳がん41件の研究
- 前立腺がん33件の研究
- 急性骨髄性白血病31件の研究
- 卵巣がん29件の研究
- 大腸癌29件の研究
- 肺がん29件の研究
- 転移性癌28件の研究
- 心不全25件の研究
- 頭頸部扁平上皮癌24件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。